Brown Advisory Inc. Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brown Advisory Inc. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,746,131 shares of the medical equipment provider's stock after buying an additional 95,249 shares during the quarter. Intuitive Surgical makes up about 1.2% of Brown Advisory Inc.'s investment portfolio, making the stock its 18th largest position. Brown Advisory Inc. owned 0.49% of Intuitive Surgical worth $911,411,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical during the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $82,517,000. Sycomore Asset Management raised its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after buying an additional 4,079 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its position in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in Intuitive Surgical by 73.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider's stock worth $132,657,000 after acquiring an additional 114,149 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In other news, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,313 shares of company stock worth $17,229,143 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ISRG shares. UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Truist Financial decreased their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $5.69 on Wednesday, reaching $536.15. 1,311,349 shares of the company were exchanged, compared to its average volume of 1,626,933. Intuitive Surgical, Inc. has a one year low of $379.67 and a one year high of $616.00. The company has a market cap of $192.17 billion, a price-to-earnings ratio of 83.64, a PEG ratio of 5.85 and a beta of 1.70. The company has a 50-day moving average of $502.67 and a 200-day moving average of $534.43.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the company posted $1.50 earnings per share. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.